Publication | Open Access

In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities

Greek Streptococcus PyogenesAntimicrobial SusceptibilityAntibioticsHmr 3647MedicineDifferent Macrolide SusceptibilitiesAntibacterial AgentAntimicrobial ChemotherapyMicrobiologyInfection ControlPharmacologyClinical MicrobiologyAntimicrobial Resistance